Page last updated: 2024-11-02

pentamidine and Anemia, Hemolytic

pentamidine has been researched along with Anemia, Hemolytic in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taguchi, H1
Takahashi, T1
Wada, Y1
Nakamura, T1
Iwamoto, A1

Other Studies

1 other study available for pentamidine and Anemia, Hemolytic

ArticleYear
Pentamidine-induced hemolytic anemia in an AIDS patient.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Anemia, Hemolytic; Antifungal Agents; Humans; Male; Middle Ag

1999